News & Events

Zahrawi Group, in partnership with Cepheid, proudly participated in the 3rd Global Pediatrics Congress at Al Habtoor Palace, Dubai. This prestigious event, which brought together leading pediatric healthcare professionals from around the world, focused on the theme “Future Med: Harnessing Genomics, Biomics, and AI for Tomorrow’s Pediatric Care.”

At the event, Zahrawi Group’s Lab team showcased and conducted a live demo of Cepheid’s POCT (CLIA waived PCR GeneXpert Xpress System), a rapid PCR test for respiratory viruses, including Flu A & B, RSV, and COVID-19 (SARS-CoV-2), with the ability to give you the results for all four pathogens in just 36 minutes. Live samples were tested to demonstrate the technology’s speed and accuracy, highlighting its critical role in diagnosing pediatric patients quickly and effectively.

Additionally, Mr. Ahmed Maidan, MEA Director of Clinical Solutions at Cepheid, presented a talk titled “Preparing for Respiratory Season: Challenges, Tactics, and Impact.” He discussed the challenges in managing seasonal respiratory infections and emphasized the importance of decentralizing molecular testing to bring it closer to patients. By implementing point-of-care testing (POCT) at emergency departments, patient management can be improved, treatment accelerated, and overall outcomes enhanced.

Our participation reflects Zahrawi Group’s commitment to supporting the region’s healthcare sector with cutting-edge solutions. By working with Cepheid, a global leader in molecular diagnostics, we are contributing to faster, more accurate diagnostics that ensure children receive the best possible care.